discussing with her client to fine-tune the deficit portfolio. At the end of the trading day, she notified her client via mobile telephone after working hours.Making securities trading decisions on behalf of
rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments) 25. Retained earnings (deficits) arising from risk
Issued and paid-up share capital 21. Stock rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments) 25
capital 20.2 Issued and paid-up share capital 21. Stock rights and warrants 22. Additional paid-in capital (discount on capital stock)) 23. Appraisal surplus 24. revaluation surplus (deficit) in investments
trade and other payables, and provision for long-term employee benefits decreased. Shareholders’ equity up 13.37 million Baht, main reason came unappropriated retained (deficit) earnings and other
. no longer being a subsidiary of the company. This decision was made because it continued to return deficit performance and letting it go would help the company to be released from the cost burden, and
that combines patient care, health promotion and beauty by providing chelation programs for detoxifying blood vessels, weight loss programs, and colon therapy services. October The Company was ranked
. However, the Company still has retained deficit within 5 years from the loss year (As at June 30, 2017, the balance was 41 million Baht) Such loss, according to Thai Accounting standard No.12, requires the
2016 because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit (loss) For year 2017, the Company has net loss at Baht 60.55 million which
equivalent to 430.43%, because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit (loss) For the 3 months period (quarter 1/2018), the Company has